BridgeBio Oncology Therapeutics, Inc. BBOT BBO-10203 — Colorectal Cancer Phase 1 BBO-10203 — Non-Small Cell Lung Cancer Phase 1 BBO-10203 — Pancreatic Ductal Adenocarcinoma Phase 1
OnKure Therapeutics, Inc. OKUR OKI-345 — Breast Cancer Preclinical OKI-355 — Vascular Anomalies Preclinical
Relay Therapeutics, Inc. RLAY zovegalisib — Breast Cancer Phase 3 zovegalisib — PIK3CA-Related Overgrowth Spectrum Phase 2